These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 22309169)
41. DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologue. Baraldi PG; Romagnoli R; Spalluto G; Cozzi P; Mongelli N; Bianchi N; Gambari R Arzneimittelforschung; 2000 Mar; 50(3):309-15. PubMed ID: 10758785 [TBL] [Abstract][Full Text] [Related]
42. Development of pyrrole-imidazole polyamide for specific regulation of human aurora kinase-A and -B gene expression. Takahashi T; Asami Y; Kitamura E; Suzuki T; Wang X; Igarashi J; Morohashi A; Shinojima Y; Kanou H; Saito K; Takasu T; Nagase H; Harada Y; Kuroda K; Watanabe T; Kumamoto S; Aoyama T; Matsumoto Y; Bando T; Sugiyama H; Yoshida-Noro C; Fukuda N; Hayashi N Chem Biol; 2008 Aug; 15(8):829-41. PubMed ID: 18721754 [TBL] [Abstract][Full Text] [Related]
44. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates. Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and in vitro cytotoxicity studies of novel pyrrolo[2,1-c][1,4]benzodiazepine (PBD)--polymade conjugates and 2,2'-PBD dimers. Reddy BS; Damayanthi Y; Reddy BS; Lown JW Anticancer Drug Des; 2000 Jun; 15(3):225-38. PubMed ID: 11049090 [TBL] [Abstract][Full Text] [Related]
46. DNA Interstrand Crosslinks by H-pin Polyamide (S)-seco-CBI Conjugates. Guo C; Asamitsu S; Kashiwazaki G; Sato S; Bando T; Sugiyama H Chembiochem; 2017 Jan; 18(2):166-170. PubMed ID: 27862755 [TBL] [Abstract][Full Text] [Related]
47. Progress and prospects of pyrrole-imidazole polyamide-fluorophore conjugates as sequence-selective DNA probes. Vaijayanthi T; Bando T; Pandian GN; Sugiyama H Chembiochem; 2012 Oct; 13(15):2170-85. PubMed ID: 23023993 [TBL] [Abstract][Full Text] [Related]
48. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners. Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402 [TBL] [Abstract][Full Text] [Related]
49. Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamides. Bando T; Iida H; Tao ZF; Narita A; Fukuda N; Yamori T; Sugiyama H Chem Biol; 2003 Aug; 10(8):751-8. PubMed ID: 12954334 [TBL] [Abstract][Full Text] [Related]
50. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Yamori T; Matsunaga A; Sato S; Yamazaki K; Komi A; Ishizu K; Mita I; Edatsugi H; Matsuba Y; Takezawa K; Nakanishi O; Kohno H; Nakajima Y; Komatsu H; Andoh T; Tsuruo T Cancer Res; 1999 Aug; 59(16):4042-9. PubMed ID: 10463605 [TBL] [Abstract][Full Text] [Related]
51. Synthesis of polyamides containing N-methylpyrrole and N-methylimidazole and their anticancer activity. Yuan G; Xiao J; Huang W; Tang F; Zhou Y Arch Pharm Res; 2002 Oct; 25(5):585-9. PubMed ID: 12433187 [TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, cytotoxic properties and preliminary DNA sequencing evaluation of CPI--N-methylpyrrole hybrids. Enhancing effect of a trans double bond linker and role of the terminal amide functionality on cytotoxic potency. Wang Y; Gupta R; Huang L; Luo W; Lown JW Anticancer Drug Des; 1996 Jan; 11(1):15-34. PubMed ID: 8639246 [TBL] [Abstract][Full Text] [Related]
54. Molecular design of alkylating pyrrole-imidazole polyamides with indole linker. Sasaki S; Narita A; Bando T; Sugiyama H Nucleic Acids Symp Ser (Oxf); 2004; (48):205-6. PubMed ID: 17150550 [TBL] [Abstract][Full Text] [Related]
55. Nitro seco analogues of the duocarmycins containing sulfonate leaving groups as hypoxia-activated prodrugs for cancer therapy. Stevenson RJ; Denny WA; Tercel M; Pruijn FB; Ashoorzadeh A J Med Chem; 2012 Mar; 55(6):2780-802. PubMed ID: 22339090 [TBL] [Abstract][Full Text] [Related]
56. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity. Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114 [TBL] [Abstract][Full Text] [Related]
57. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores. Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786 [TBL] [Abstract][Full Text] [Related]
58. Specific adenine alkylation by pyrrole-imidazole CBI conjugates. Bando T; Narita A; Sasaki S; Sugiyama H J Am Chem Soc; 2005 Oct; 127(40):13890-5. PubMed ID: 16201810 [TBL] [Abstract][Full Text] [Related]
59. Pyrrolobenzimidazoles linked to heterocycles and peptides. Design of DNA base pair specific phosphate hydrolyzing agents and novel cytotoxic agents. Ghodousi A; Huang X; Cheng Z; Skibo EB J Med Chem; 2004 Jan; 47(1):90-100. PubMed ID: 14695823 [TBL] [Abstract][Full Text] [Related]
60. Antitumor activity of sequence-specific alkylating agents: pyrolle-imidazole CBI conjugates with indole linker. Shinohara K; Bando T; Sasaki S; Sakakibara Y; Minoshima M; Sugiyama H Cancer Sci; 2006 Mar; 97(3):219-25. PubMed ID: 16542219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]